Simvastatin interferes with process outgrowth and branching of oligodendrocytes
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Statins have attracted interest as a treatment option for multiple sclerosis (MS) because of their pleiotropic antiinflammatory and immunomodulatory effects. However, contradictory results have been described when they are applied to oligodendrocytes (OLGs), the cell type predominantly affected in MS. In this study we focus on the in vitro effect of statins on process outgrowth in OLN‐93 cells, a well‐characterized OLG‐derived cell line, and primary cultures of neonatal rat OLGs. Application of the lipophilic simvastatin, as low as 0.1–1 μM, disturbs process formation of both cell types, leading to less ramified cells. We show that both protein isoprenylation and cholesterol synthesis are required for the normal differentiation of OLGs. It is further demonstrated that the expression of 2′,3′‐cyclic‐nucleotide‐3′ phosphodiesterase (CNP) and tubulin is lowered, concomitant with a reduction of membrane‐bound CNP as well as tubulin. Therefore, we propose that lack of isoprenylation of CNP could help to explain the altered morphological and biochemical differentiation state of treated OLGs. Moreover, expression of specific myelin markers, such as myelin basic protein, myelin‐associated glycoprotein, and myelin oligodendrocyte glycoprotein, was compromised after treatment. We conclude that simvastatin treatment has detrimental effects on OLG process outgrowth, the prior step in (re)myelination, thereby mortgaging long‐term healing of MS lesions. © 2010 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Remyelination in the CNS: from biology to therapy
Franklin, R. J. M., & ffrench-Constant, C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2480 · Cited by 1,544 · cited 2×
“In view of the notion that the inflammatory response itself might have beneficial effects and serve remyelination (Foote and Blakemore, 2005; Franklin and ffrench-Constant, 2008), blocking inflammatory processes with statins in the end might impair myelin repair.”
BackgroundMethodDisruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination
Lappe-Siefke, C., Goebbels, S., Gravel, M., Nicksch, E., Lee, J., Braun, P. E., Griffiths, I. R., & Nave, K.-A. (2003) · Nature Genetics · doi:10.1038/ng1095 · Cited by 1,036 · cited 2×
“…and membrane expansion during myelination and in maintaining axonal integrity (Sprinkle, 1989; Wilson and Brophy, 1989; Agrawal et al., 1990; De Angelis and Braun, 1994; Gravel et al., 1996; Yin et al., 1997; Lee et al., 2001, 2005; Dyer, 2002; Lappe-Siefke et al., 2003; Rasband et al., 2005).”
BackgroundHigh cholesterol level is essential for myelin membrane growth
Saher, G., Brügger, B., Lappe-Siefke, C., Möbius, W., Tozawa, R.-I., Wehr, M. C., Wieland, F., Ishibashi, S., & Nave, K.-A. (2005) · Nature Neuroscience · doi:10.1038/nn1426 · Cited by 799 · cited 1×
“Cholesterol, the end product of the MVA pathway, is essential for myelin membrane growth (Saher et al., 2005) and is a key component of membranes and particularly of lipid rafts, which are cholesterol- and sphingolipid-enriched membrane domains (Pike, 2006).”
BackgroundNew insights into the pharmacodynamic and pharmacokinetic properties of statins
Corsini, A., Bellosta, S., Baetta, R., Fumagalli, R., Paoletti, R., & Bernini, F. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00045-5 · Cited by 796 · cited 2×
“Several of these processes are essential for myelination (Corsini et al., 1999; Menge et al., 2005a,b).”
BackgroundSafety of Statins: Focus on Clinical Pharmacokinetics and Drug Interactions
Bellosta, S., Paoletti, R., & Corsini, A. (2004) · Circulation · doi:10.1161/01.cir.0000131519.15067.1f · Cited by 578 · cited 1×
“Plasma concentrations in patients receiving 80 mg simvastatin orally per day yielded levels of 10–100 lg/liter (equivalent to 0.05–0.5 lM; Bellosta et al., 2004).”
BackgroundInfluentialEndogenous progenitors remyelinate demyelinated axons in the adult CNS
Gensert, J. M., & Goldman, J. E. (1997) · Neuron · doi:10.1016/s0896-6273(00)80359-1 · Cited by 544
Liang, X., Draghi, N. A., & Resh, M. D. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5319-03.2004 · Cited by 255
Ghittoni, R., Patrussi, L., Pirozzi, K., Pellegrini, M., Lazzerini, P. E., Capecchi, P. L., Pasini, F. L., & Baldari, C. T. (2005) · The FASEB Journal · doi:10.1096/fj.04-2702fje · Cited by 154 · cited 2×
“Also, in studies with exposure to higher concentrations of statins, no significant differences in cholesterol levels were observed either in lymphocytes (Ghittoni et al., 2005) or in neuronal cells (Meske et al.”
BackgroundStatin Therapy Inhibits Remyelination in the Central Nervous System
Miron, V. E., Zehntner, S. P., Kuhlmann, T., Ludwin, S. K., Owens, T., Kennedy, T. E., Bedell, B. J., & Antel, J. P. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080947 · Cited by 141
The Cytoskeleton in Oligodendrocytes: Microtubule Dynamics in Health and Disease
Richter-Landsberg, C. (2008) · Journal of Molecular Neuroscience · doi:10.1007/s12031-007-9017-7 · Cited by 89
Cited by
Mathews, E. S., Mawdsley, D. J., Walker, M., Hines, J. H., Pozzoli, M., & Appel, B. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.4587-13.2014 · Cited by 98
“…with oligodendrocyte differentiation, myelination, and remyelination in cell culture and rodent models (Klopfleisch et al., 2008; Maier et al., 2009; Miron et al., 2009; Smolders et al., 2010), but whether these defects result from deficits of isoprenoids, cholesterol, or both has not been known.”
BackgroundMathews, E. S., & Appel, B. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0726-16.2016 · Cited by 97
Butterfield, D. A., Barone, E., & Mancuso, C. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.04.007 · Cited by 80
“Simvastatin treatment had a detrimental effect on oligodentrocyte outgrowth, a key step in the re(myelination) process [28], particularly in the early myelination stage [29] (Figure 1).”
BackgroundLiver X receptors regulate cholesterol homeostasis in oligodendrocytes
Nelissen, K., Mulder, M., Smets, I., Timmermans, S., Smeets, K., Ameloot, M., & Hendriks, J. J. A. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.22743 · Cited by 80
“…(180 rpm, 1 hr), oligodendrocyte progenitor cells grown on top of a layer of astrocytes were collected by shake off (240 rpm, 20–24 hr; Innova 4000 shaking incubator; New Brunswick Scientific NV-SA, Rotselaar, Belgium) as previously described (McCarthy and de Vellis, 1980; Smolders et al., 2010).”
MethodSelf-citationLin, J.-P., Mironova, Y. A., Shrager, P., & Giger, R. J. (2017) · eLife · doi:10.7554/elife.30498 · Cited by 64
Metadata
- Authors
- Smolders, I., Smets, I., Maier, O., vandeVen, M., Steels, P., & Ameloot, M.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 2010-09-20
- Volume
- 88
- Issue
- 15
- Pages
- 3361-3375
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W2166481259
- Cited by
- 20
- References
- 10
- FWCI
- 0.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Simvastatin interferes with process outgrowth and branching of oligodendrocytes. https://app.cochat.ai/papers/10.1002/jnr.22490
- The paper
- Smolders, I., Smets, I., Maier, O., vandeVen, M., Steels, P., & Ameloot, M. (2010). Simvastatin interferes with process outgrowth and branching of oligodendrocytes. Journal of Neuroscience Research. https://doi.org/10.1002/jnr.22490
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.